|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.84 USD | +0.45% |
|
+6.67% | +3.85% |
| 01-08 | Colgate-Palmolive 'Well Positioned' vs Peers in Difficult CPG Market, Morgan Stanley Says | MT |
| 01-08 | Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns | RE |
| Capitalization | 65.68B 56.24B 52.3B 48.76B 91.11B 5,920B 97.72B 602B 237B 2,832B 246B 241B 10,383B | P/E ratio 2025 * |
22.8x | P/E ratio 2026 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise value | 72.84B 62.38B 58.01B 54.08B 101B 6,565B 108B 668B 263B 3,141B 273B 268B 11,516B | EV / Sales 2025 * |
3.59x | EV / Sales 2026 * | 3.47x |
| Free-Float |
54.92% | Yield 2025 * |
2.56% | Yield 2026 * | 2.61% |
Last Transcript: Colgate-Palmolive Company
| 1 day | +0.45% | ||
| 1 week | +6.67% | ||
| Current month | +3.85% | ||
| 1 month | +4.75% | ||
| 3 months | +6.60% | ||
| 6 months | -7.64% | ||
| Current year | +3.85% |
| 1 week | 76.51 | 82.16 | |
| 1 month | 75.96 | 82.16 | |
| Current year | 75.96 | 82.16 | |
| 1 year | 74.54 | 100.18 | |
| 3 years | 67.62 | 109.3 | |
| 5 years | 67.62 | 109.3 | |
| 10 years | 57.41 | 109.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Noel Wallace
CEO | Chief Executive Officer | 61 | 01/04/2019 |
Stanley Sutula
DFI | Director of Finance/CFO | 60 | 08/11/2020 |
Gillian Barclay
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Cahill
BRD | Director/Board Member | 68 | 05/10/2005 |
Noel Wallace
CHM | Chairman | 61 | 31/03/2020 |
John Bilbrey
BRD | Director/Board Member | 69 | 10/03/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | +6.67% | -5.79% | +6.79% | 65.68B | ||
| +0.92% | +2.12% | -9.76% | -4.32% | 332B | ||
| +0.56% | +1.52% | -6.41% | +1.32% | 138B | ||
| +1.42% | +0.93% | -1.83% | -7.10% | 67.96B | ||
| -0.68% | +4.49% | +50.69% | -56.90% | 40.98B | ||
| +1.16% | +1.28% | -18.76% | - | 32.24B | ||
| +3.12% | +4.39% | -22.32% | -9.42% | 24.15B | ||
| 0.00% | +0.96% | -9.40% | -9.28% | 19.5B | ||
| +0.54% | -0.65% | +6.66% | +35.08% | 13.94B | ||
| +0.31% | +0.54% | +2.59% | -3.84% | 10.27B | ||
| Average | +0.75% | +1.03% | -1.43% | -5.30% | 74.46B | |
| Weighted average by Cap. | +0.80% | +0.57% | -5.05% | -5.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.28B 17.36B 16.15B 15.05B 28.13B 1,827B 30.17B 186B 73.11B 874B 76.04B 74.48B 3,205B | 20.98B 17.96B 16.71B 15.58B 29.1B 1,891B 31.21B 192B 75.65B 905B 78.68B 77.06B 3,317B |
| Net income | 2.92B 2.5B 2.33B 2.17B 4.06B 264B 4.35B 26.83B 10.55B 126B 10.97B 10.74B 462B | 3.1B 2.65B 2.47B 2.3B 4.3B 279B 4.61B 28.42B 11.17B 134B 11.62B 11.38B 490B |
| Net Debt | 7.17B 6.14B 5.71B 5.32B 9.94B 646B 10.66B 65.74B 25.84B 309B 26.87B 26.32B 1,133B | 7.09B 6.07B 5.65B 5.26B 9.84B 639B 10.55B 65.04B 25.57B 306B 26.59B 26.05B 1,121B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 82.05 $ | +0.70% | 3,338,068 |
| 09/01/26 | 81.48 $ | +0.75% | 6,178,085 |
| 08/01/26 | 80.87 $ | +4.90% | 10,125,305 |
| 07/01/26 | 77.09 $ | -0.14% | 8,683,872 |
| 06/01/26 | 77.20 $ | +0.35% | 8,387,809 |
Delayed Quote Nyse, January 12, 2026 at 06:21 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















